key: cord-0789842-wbk363w1
authors: Hashimoto, Rina; Sakamoto, Ayaka; Deguchi, Sayaka; Yi, Renxing; Sano, Emi; Hotta, Akitsu; Takahashi, Kazutoshi; Yamanaka, Shinya; Takayama, Kazuo
title: Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
date: 2021-10-20
journal: Mol Ther Nucleic Acids
DOI: 10.1016/j.omtn.2021.10.016
sha: 24bb84183692d0676ff109fa14b8f3dfee947490
doc_id: 789842
cord_uid: wbk363w1

It has been reported that many receptors and proteases are required for SARS-CoV-2 infection. Although angiotensin-converting enzyme2 (ACE2) is the most important of these receptors, little is known about the contribution of other genes. In this study, we examined the roles of neuropilin-1, basigin, transmembrane serine proteases (TMPRSSs), and cathepsins (CTSs) in SARS-CoV-2 infection using the CRISPR interference system and ACE2-expressing human iPS cells. Double-knockdown of TMPRSS2 and CTSB reduced the viral load to 0.036±0.021%. Consistently, the combination of the CTPB inhibitor CA-074 methyl ester and the TMPRSS2 inhibitor Camostat reduced the viral load to 0.0078±0.0057%. This result was confirmed using four SARS-CoV-2 variants (B.1.3, B.1.1.7, B.1.351, and B.1.1.248). The simultaneous use of these two drugs reduced viral load to less than 0.01% in both female and male iPS cells. These findings suggest that compounds targeting TMPRSS2 and CTSB exhibit highly efficient antiviral effects independent of gender and SARS-CoV-2 variant.

To develop a therapeutic agent for coronavirus disease 2019 , it is 49 necessary to elucidate the infection mechanism of severe acute respiratory syndrome 50 coronavirus 2 (SARS-CoV-2). During infection, SARS-CoV-2 Spike (S) protein binds 51 to angiotensin-converting enzyme2 (ACE2) expressed on the cell surface and is cleaved 52 by proteases such as transmembrane protease serine 2 (TMPRSS2), 1 causing S protein 53 to split into S1 and S2 domains. SARS-CoV-2 invades into a cell by fusing cell and viral 54 membrane using the S2 domain. 2 Therefore, SARS-CoV-2 infection is thought to 55 depend on the expression of ACE2 and TMPRSS2 in host cells. 1 However, recently it 56 has become evident that molecular factors besides ACE2 and TMPRSS2 play important 57 roles in SARS-CoV-2 infection. 58 For example, neuropilin-1 (NRP1) and basigin (BSG; known as CD147) act as 59 SARS-CoV-2 receptors. Previous reports showed that SARS-CoV-2 infects neurons and 60 T cells via NRP1 3, 4 and BSG, 5 respectively. However, few reports have compared the 61 contribution rates of NRP1 and CD147 in the viral infection. In regards to the 62 processing of S protein, it has been reported that several cellular type II transmembrane 63 serine proteases (TTSPs) and cathepsins (CTSs) contribute to the cleavage of S protein. 64 TTSPs are expressed on the cell surface, while CTSs are expressed in the endosome. receptors and proteases are the promising targets for effective In this study, we used the CRISPR interference (CRISPRi) system 9 and induce 74 pluripotent stem (iPS) cells to compare the functions of these receptors and proteases in 75 the SARS-CoV-2 infection. The CRISPRi system can selectively suppress the 76 expression of a target gene using catalytically dead Cas9 (dCas9) fused with krüppel 77 associated box (KRAB) suppressor domain and short guide RNA (sgRNA). 10 We have 78 previously reported that ACE2 is essential for SARS-CoV-2 infection in 

Expression of SARS-CoV-2-related receptors and proteases in undifferentiated iPS 89 cells 90 HEK293 (embryonic kidney), Calu-3 (lung cancer), and Caco-2 (colorectal 97 adenocarcinoma) cell lines (Fig. S1) . The gene expression profile in these cell lines was 98 also correlated with the gene expression profile in human alveoli (Fig. S2) . Therefore, 99 in the following experiments, we analyzed the functions of the receptors and proteases 100 in SARS-CoV-2 infection using human iPS cells. 

To elucidate the functions of receptors and proteases other than ACE2 in 104 SARS-CoV-2 infection, ACE2-overexpressing iPS cells (ACE2-iPS cells) and the 105 CRISPRi system were used. ACE2-expressing adenovirus (Ad) vectors (Ad-ACE2) 106 were used to overexpress ACE2. To decrease the expression of the target gene, WTB 107 CRISPRi Gen1 cells, which express the fusion protein of KRAB and dCas9 under 108 control of doxycycline (DOX)-inducible promoter, 10 were used ( Fig. 2A) . To suppress 109 the expression levels of BSG, CTSL, CTSB, TMPRSS2, 4, 11E, 13, NRP1, and IFNAR2, 110 we designed sgRNAs that target these genes. The iPS cells were transfected with 111 plasmids expressing sgRNAs, mKate2, and blasticidin S resistance genes ( Fig. 2A) . By 112 performing blasticidin S selection and single-cell cloning based on the mKate2 113 brightness, the iPS cell clone that most strongly expressed the sgRNAs was selected 114 (Fig. 2B) . From this clone, we established 9 iPS cell lines that express sgRNAs 115 targeting the 9 genes, respectively. After suppressing the expression levels of the target 116 gene in ACE2-iPS cells by DOX-mediated dCas9-KRAB expression (Fig. S3) , CoV-2 infection was performed (Fig. 2C) . The suppression of CTSL, CTSB, and 118 TMPRSS2 reduced the viral RNA copy numbers in ACE2-iPS cells to 11.7±3.77%, 119 0.84±0.062%, and 20.6±10.4%, respectively. Consistently, the suppression of TMRPSS2 decreased the number of ACE2-iPS cells expressing the nucleocapsid (N) protein (Fig. 121 2D). We also confirmed that the expression levels of the target gene can be suppressed 122 by DOX treatment in the presence of SARS-CoV-2 (Fig. S4) . These results suggest that 

iPS cells 146 Lastly, we examined whether a dual inhibition of TMRPSS2 and CTSB 147 synergistically inhibit SARS-CoV-2 infection in ACE2-iPS cells. The viral RNA copy 148 number in the infected CTSB and TMPRSS2 double knockdown cells was lower than 149 that in the infected single gene knockdown cells (Fig. 4A ). In addition, we investigated 

In this study, we elucidated the functions of receptors and proteases in 182 undifferentiated iPS cells, but similar experiments using somatic cells derived from 183 these iPS cells should also be done. Because the expression profiles of SARS-CoV-2-184 related genes differ among somatic cell types, the contribution rate of these genes will 185 vary. Because iPS cells are easier to genome edit than primary somatic cells, the 186 differentiation of genome edited iPS cells to different cell types will provide a human 187 model to search for more SARS-CoV-2-related genes that regulate infection. We hope 188 that iPS cells and the CRISPRi system will accelerate the discovery of genes that can 189 prevent SARS-CoV-2 infection and replication. Table S1 . Table   289 S2.

Immunofluorescence staining 292 For the immunofluorescence staining of human iPS cells, the cells were fixed 293 with 4% paraformaldehyde in PBS at 4°C. After blocking the cells with PBS containing 294 2% bovine serum albumin and 0.2% Triton X-100 at room temperature for 45 min, the 295 cells were incubated with a primary antibody at 4°C overnight and then with a 296 secondary antibody at room temperature for 1 h. All antibodies used in this report are 297 described in Table S3 . 

SARS-CoV-2 research using human pluripotent stem cells 399 and organoids. Stem cells translational medicine

Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by 402 TMPRSS2

Genomewide association study of severe Covid-19 with 404 respiratory failure